ASH Clinical News March 2015 | Page 13

UP FRONT Pulling Back the Curtain Beverly S. Mitchell, MD We can learn much more from the innovators and mentors in hematology and oncology than clinical expertise. In Pulling Back the Curtain, we speak with hematology/oncology professionals about how they approach their leadership positions and what advice they would give those just getting started in the field. Beverly S. Mitchell, MD, Director of the Stanford Cancer Institute, spoke with ASH Clinical News about knowing your passion, combining a love of research and medicine, and showing determination in the face of obstacles – bureaucratic or otherwise. Beverly S. Mitchell, MD, on a zipline in Blue Creek Rainforest, Belize. When did you know you wanted to pursue a career in medicine? As early as I can remember, I knew I wanted to be a doctor. My father was a physician, so I have been around medicine my entire life, really. He was very much someone I wanted to emulate. As a kid, I would go to the hospital with him – he was a gynecologic oncologist – and wait in his office while he did his rounds. The whole idea of medicine was very ASHClinicalNews.org exciting to me. The first “real” job I ever had was in my career path – when I finished medical school, I was a resident and assistant professor. Is it worth asking if there is another career you could ever see yourself in? Not really! Well, I remember back in seventh grade, we were asked to make a list of possible career choices. I was really fishing for something, but I ended up with choices like “X-ray technician” – all were medicine-related. So, I truly did not see myself taking any other path. Along with your father, who else played a role in shaping your career? Two people had a major impact on my career – John W. Adamson, MD, and William Kelley, MD. Initially, my desire was to be a physician, and, basically, take care of patients. But both of these mentors helped me to see the value of research in medicine. Dr. Adamson was a hematologist at the University of Washington when I was a resident in the early 1970s. Overall, this was a fantastic place for hematology at that time; his excitement about research was contagious and drew me into the laboratory. This was an environment that fostered research and tackling complicated ASH Clinical News 9